Public filings / RVMD on Yahoo Finance (opens in a new tab)
RVMD: insider buying, 13F holders, analyst moves
Revolution Medicines Inc - US
A summary of public filings about Revolution Medicines Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
8 of our 100 managers hold RVMD
Combined reported value $5.76B.
Holders among our 100 managers: 4 in Q3 2023, 8 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Farallon Capital | $2.54B | 14.85% | Unchanged |
| Baker Bros. Advisors | $2.14B | 10.74% | Added |
| Deerfield Company | $448.0M | 4.67% | Added |
| Avoro Capital Advisors | $430.2M | 3.86% | Trimmed |
| Perceptive Advisors | $98.8M | 1.53% | Added |
| Duquesne Family Office | $74.8M | 1.72% | Added |
| Samlyn Capital | $28.3M | 0.47% | Trimmed |
| Tudor Investment | $3.0M | 0.01% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.